David Rostov
David Rostov is Chief Financial Officer at LogicGate and Executive Officer at Aurion Biotech, Inc.
Aurion Biotech Raises $120M to Advance Cell Therapy for Corneal Edema Affecting Millions
Aurion Biotech, a spinoff of CorneaGen, has raised $120 million to advance its cell therapy for treating corneal edema caused by endothelial dysfunction, a condition leading to impaired vision or blindness affecting about 4% of people over 40 in the U.S. The therapy uses cultured corneal cells from a single donor to treat multiple patients with a less complex procedure than corneal transplantation.
Smartsheet CFO Jennifer Ceran joins Auth0 board; Auth0 hires three execs; Outreach opens NYC office led by David Rubinstein
Smartsheet CFO Jennifer Ceran joined the board of Bellevue identity provider Auth0 as she prepares to retire, and Auth0 added three senior hires: Holly Files (SVP customer success), Cassio Sampaio (VP product) and Ken Oestreich (VP product marketing). Separately, Seattle sales-engagement firm Outreach is opening a New York City office led by David Rubinstein as part of its U.S. and international expansion.
Organizations
-
Aurion Biotech Executive Officer 2022–present, Chief Financial Officer · current
-
LogicGate Chief Financial Officer · current
